Insider Activity of Doyle John Brendan
According to the SEC Form 4 filings, Doyle John Brendan, being in a position of
- Chief Financial Officer at Cognition Therapeutics, Inc.,оver the last 12 months, has bought 10000 shares for $11,300, and sold 0 shares,over all time since 2026-04-16, has bought 10000 shares for $11,300, and sold 0 shares.
Biography of Doyle John Brendan
No biography is available at this moment.